1. Department of Biomedical Engineering, State Key Laboratory of Natural Medicines and School of Life Science and Technology, China Pharmaceutical University, 24 Tongjia Lane, Gulou District, Nanjing 210009, China.
Theranostics. 2013 Aug 3;3(9):633-49. doi: 10.7150/thno.6630. eCollection 2013.
Uniform gold nanostars (Au NS) were conjugated with cyclic RGD (cRGD) and near infrared (NIR) fluorescence probe (MPA) or anti-cancer drug (DOX) to obtain multi-functional nanoconstructs, Au-cRGD-MPA and Au-cRGD-DOX respectively. The NIR contrast agent Au-cRGD-MPA was shown to have low cytotoxicity. Using tumor cells and tumor bearing mice, these imaging nanoparticles demonstrated favorable tumor-targeting capability mediated by RGD peptide binding to its over-expressed receptor on the tumor cells. The multi-therapeutic analogue, Au-cRGD-DOX, integrates targeting tumor, chemotherapy and photo-thermotherapy into a single system. The synergistic effect of photo-thermal therapy and chemotherapy was demonstrated in different tumor cell lines and in vivo using S180 tumor-bearing mouse models. The viability of MDA-MB-231 cells was only 40 % after incubation with Au-cRGD-DOX and irradiation with NIR light. Both tail vein and intratumoral injections showed Au-cRGD-DOX treated mice exhibiting the slowest tumor increase. These results indicate that the multifunctional nanoconstruct is a promising combined therapeutic agent for tumor-targeting treatment, with the potential to enhance the anti-cancer treatment outcomes.
均一的金纳米星(Au NS)与环状 RGD(cRGD)和近红外(NIR)荧光探针(MPA)或抗癌药物(DOX)偶联,得到多功能纳米构建体,分别为 Au-cRGD-MPA 和 Au-cRGD-DOX。NIR 对比剂 Au-cRGD-MPA 表现出低细胞毒性。使用肿瘤细胞和荷瘤小鼠,这些成像纳米颗粒通过 RGD 肽与肿瘤细胞上过表达的受体结合,表现出良好的肿瘤靶向能力。多治疗类似物 Au-cRGD-DOX 将靶向肿瘤、化学疗法和光热疗法整合到一个单一的系统中。使用 S180 荷瘤小鼠模型在不同的肿瘤细胞系和体内证明了光热疗法和化学疗法的协同作用。与 Au-cRGD-DOX 孵育并用 NIR 光照射后,MDA-MB-231 细胞的存活率仅为 40%。尾静脉和瘤内注射均表明,接受 Au-cRGD-DOX 治疗的小鼠肿瘤增长最慢。这些结果表明,多功能纳米构建体是一种有前途的肿瘤靶向治疗联合治疗剂,有可能增强抗癌治疗效果。